Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.28 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.54.
Market Cap
9.28T
Revenue
4.67T
Profits
191.26B
PE Ratio
48.54
Profit Margin
4.10%
Dividend Yield
0.39%
1046 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | -0.01% | 1,659,192 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 644.82B | -1.61% | 5,621,440 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 465.26B | -1.12% | 4,004,301 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 368.30B | 0.40% | 8,203,975 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 336.54B | -0.76% | 3,286,574 | 450.53B |
| 6 | NVS | Novartis AG | 275.26B | -0.80% | 1,598,714 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 254.56B | -1.17% | 3,372,145 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 251.28B | 0.15% | 1,850,847 | 46.34B |
| 9 | AMGN | Amgen Inc. | 229.03B | 1.32% | 3,738,322 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 187.58B | -0.61% | 5,322,197 | 30.46B |
| 11 | ABT | Abbott Laboratories | 174.68B | -0.03% | 8,049,046 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 168.71B | -1.03% | 9,403,506 | 50.34B |
| 13 | PFE | Pfizer Inc. | 163.69B | - | 33,309,394 | 63.70B |
| 14 | DHR | Danaher Corporation | 158.95B | -0.54% | 3,592,748 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 145.61B | -0.63% | 1,885,691 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 133.51B | -0.18% | 688,925 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.41B | -1.60% | 15,839,210 | 49.19B |
| 18 | MDT | Medtronic plc | 111.40B | -2.69% | 19,445,985 | 37.54B |
| 19 | CVS | CVS Health Corporation | 111.40B | -0.85% | 7,116,048 | 412.65B |
| 20 | SYK | Stryker Corporation | 106.93B | 1.26% | 2,793,518 | 25.84B |
| 21 | MCK | McKesson Corporation | 100.83B | 1.00% | 476,911 | 410.98B |
| 22 | GSK | GSK plc | 98.21B | -0.70% | 2,892,717 | 44.05B |
| 23 | SNY | Sanofi | 97.03B | -1.07% | 3,039,940 | 55.89B |
| 24 | HCA | HCA Healthcare, Inc. | 93.45B | -0.22% | 883,884 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 85.17B | -0.47% | 930,752 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 81.23B | 3.13% | 13,277,929 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 74.94B | -0.23% | 804,314 | 15.53B |
| 28 | CI | The Cigna Group | 72.73B | 1.26% | 1,978,745 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 63.59B | -0.52% | 14,636,110 | 21.00B |
| 30 | ARGX | argenx SE | 60.12B | -0.16% | 311,042 | 5.32B |
| 31 | NTRA | Natera, Inc. | 59.75B | 0.67% | 2,058,204 | 2.71B |
| 32 | COR | Cencora, Inc. | 58.70B | 1.25% | 1,268,377 | 332.77B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 58.12B | -2.06% | 2,415,171 | 28.42B |
| 34 | CAH | Cardinal Health, Inc. | 51.85B | 1.64% | 973,562 | 254.25B |
| 35 | EW | Edwards Lifesciences Corporation | 50.77B | 1.44% | 3,383,124 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 49.57B | -1.01% | 1,534,745 | 22.48B |
| 37 | A | Agilent Technologies, Inc. | 49.35B | -0.10% | 2,053,880 | 7.37B |
| 38 | HUM | Humana Inc. | 46.46B | -0.71% | 1,892,579 | 145.68B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 46.39B | 2.39% | 6,822,039 | 17.32B |
| 40 | MDLN | Medline Inc. | 45.99B | -0.26% | 11,884,734 | 29.94B |
| 41 | VEEV | Veeva Systems Inc. | 45.10B | -0.50% | 1,104,978 | 3.46B |
| 42 | IQV | IQVIA Holdings Inc. | 44.28B | -0.73% | 1,174,118 | 16.98B |
| 43 | RVMD | Revolution Medicines, Inc. | 43.83B | 1.36% | 1,722,103 | - |
| 44 | WAT | Waters Corporation | 43.55B | 0.07% | 626,337 | 4.64B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 42.02B | 0.83% | 648,930 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 41.53B | -0.47% | 372,800 | 6.13B |
| 47 | ILMN | Illumina, Inc. | 41.07B | 0.04% | 2,229,587 | 4.49B |
| 48 | HLN | Haleon plc | 39.21B | -1.09% | 20,160,286 | 14.80B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.00B | -0.51% | 787,074 | 4.80B |
| 50 | BIIB | Biogen Inc. | 33.55B | -0.71% | 1,161,103 | 10.03B |
| 51 | RPRX | Royalty Pharma plc | 33.48B | -0.26% | 2,885,093 | 2.54B |
| 52 | DXCM | DexCom, Inc. | 32.69B | -0.05% | 3,121,837 | 4.97B |
| 53 | RMD | ResMed Inc. | 31.88B | 0.33% | 949,369 | 5.65B |
| 54 | ALC | Alcon Inc. | 31.49B | 0.28% | 2,288,520 | 10.86B |
| 55 | MTD | Mettler-Toledo International Inc. | 30.80B | -0.51% | 144,788 | 4.13B |
| 56 | CNC | Centene Corporation | 30.73B | -0.51% | 4,266,740 | 180.30B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 30.02B | -0.48% | 3,312,404 | 21.27B |
| 58 | ZTS | Zoetis Inc. | 29.05B | -1.58% | 3,521,311 | 9.53B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.51B | 0.26% | 560,022 | 3.33B |
| 60 | ROIV | Roivant Sciences Ltd. | 26.36B | -1.30% | 6,587,689 | 7.53M |
| 61 | DGX | Quest Diagnostics Incorporated | 25.60B | -2.38% | 1,525,891 | 11.56B |
| 62 | INSM | Insmed Incorporated | 25.25B | -1.73% | 1,668,350 | 1.14B |
| 63 | LH | Labcorp Holdings Inc. | 25.04B | -0.25% | 613,109 | 14.35B |
| 64 | INCY | Incyte Corporation | 24.97B | -1.30% | 1,718,558 | 5.82B |
| 65 | BNTX | BioNTech SE | 24.76B | -0.51% | 736,903 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 24.07B | -1.35% | 816,248 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 23.85B | 0.23% | 1,658,443 | 1.18B |
| 68 | GMAB | Genmab A/S | 20.99B | 0.59% | 3,827,541 | 4.13B |
| 69 | VTRS | Viatris Inc. | 20.81B | -0.82% | 13,858,063 | 14.74B |
| 70 | THC | Tenet Healthcare Corporation | 20.74B | -0.13% | 448,112 | 21.81B |
| 71 | UTHR | United Therapeutics Corporation | 20.65B | -0.84% | 439,863 | 3.15B |
| 72 | STE | STERIS plc | 20.54B | -0.17% | 454,302 | 6.04B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.42B | -0.31% | 1,461,957 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.36B | 1.00% | 250,692 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 17.05B | 1.16% | 1,601,167 | 2.91B |
| 76 | SOLV | Solventum Corporation | 15.20B | -0.25% | 848,690 | 8.31B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.08B | -2.49% | 777,830 | 4.60B |
| 78 | ASND | Ascendis Pharma A/S | 14.98B | -0.86% | 741,863 | 1.20B |
| 79 | TEM | Tempus AI, Inc. | 14.90B | -2.94% | 6,327,984 | 1.43B |
| 80 | EXEL | Exelixis, Inc. | 14.53B | 0.48% | 2,244,165 | 2.44B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.13B | 0.47% | 661,449 | 4.00B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 14.06B | -1.49% | 1,499,017 | 3.37B |
| 83 | ICLR | ICON Public Limited Company | 13.14B | -2.97% | 1,442,640 | 8.29B |
| 84 | SMMT | Summit Therapeutics Inc. | 13.08B | 5.88% | 27,339,980 | - |
| 85 | BBIO | BridgeBio Pharma, Inc. | 12.90B | -0.96% | 3,597,122 | 713.07M |
| 86 | HALO | Halozyme Therapeutics, Inc. | 12.66B | -1.18% | 2,872,922 | 1.66B |
| 87 | PEN | Penumbra, Inc. | 12.56B | -0.10% | 189,840 | 1.50B |
| 88 | CORT | Corcept Therapeutics Incorporated | 12.40B | -0.77% | 962,679 | 830.81M |
| 89 | EHC | Encompass Health Corporation | 12.19B | -0.37% | 871,864 | 6.21B |
| 90 | BAX | Baxter International Inc. | 12.14B | -0.04% | 6,685,718 | 11.47B |
| 91 | FMS | Fresenius Medical Care AG | 11.77B | -2.96% | 1,379,119 | 22.19B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.77B | -1.47% | 214,358 | 1.28B |
| 93 | TXG | 10x Genomics, Inc. | 11.73B | 1.74% | 3,453,514 | 616.91M |
| 94 | TWST | Twist Bioscience Corporation | 11.67B | 3.64% | 3,680,756 | 431.80M |
| 95 | BTSG | BrightSpring Health Services, Inc. | 11.60B | -1.50% | 1,643,199 | 14.37B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.59B | 0.69% | 1,807,465 | 3.41B |
| 97 | TECH | Bio-Techne Corporation | 11.35B | -0.18% | 3,385,176 | 1.22B |
| 98 | ELAN | Elanco Animal Health Incorporated | 11.30B | 0.71% | 5,373,410 | 5.02B |
| 99 | SNN | Smith & Nephew plc | 11.24B | -0.48% | 673,026 | 6.30B |
| 100 | DVA | DaVita Inc. | 11.17B | -1.62% | 634,854 | 14.01B |
| 101 | RGEN | Repligen Corporation | 10.98B | 0.25% | 1,135,004 | 785.10M |
| 102 | RDY | Dr. Reddy's Laboratories Limited | 10.85B | 2.72% | 4,804,295 | 3.50B |
| 103 | COO | The Cooper Companies, Inc. | 10.77B | 0.11% | 5,404,248 | 4.24B |
| 104 | UHS | Universal Health Services, Inc. | 10.36B | -0.99% | 639,438 | 18.11B |
| 105 | AVTR | Avantor, Inc. | 10.31B | -0.33% | 6,911,473 | 6.56B |
| 106 | ALGN | Align Technology, Inc. | 10.23B | -0.68% | 937,275 | 4.14B |
| 107 | GMED | Globus Medical, Inc. | 10.16B | 1.22% | 1,579,447 | 3.14B |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.15B | 0.49% | 261,682 | 2.59B |
| 109 | ENSG | The Ensign Group, Inc. | 10.14B | -0.47% | 335,664 | 5.49B |
| 110 | KRYS | Krystal Biotech, Inc. | 9.92B | -0.60% | 225,791 | 440.48M |
| 111 | MOH | Molina Healthcare, Inc. | 9.87B | -0.14% | 661,205 | 42.47B |
| 112 | BRKR | Bruker Corporation | 9.83B | 1.94% | 1,746,565 | 3.50B |
| 113 | AXSM | Axsome Therapeutics, Inc. | 9.75B | -4.00% | 1,577,597 | 776.57M |
| 114 | HSIC | Henry Schein, Inc. | 9.47B | -1.19% | 978,765 | 13.60B |
| 115 | IBRX | ImmunityBio, Inc. | 9.36B | 3.64% | 8,366,558 | 165.79M |
| 116 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.36B | 1.21% | 2,895,064 | 669.50M |
| 117 | GKOS | Glaukos Corporation | 9.35B | -0.01% | 638,201 | 612.84M |
| 118 | PODD | Insulet Corporation | 9.21B | -0.20% | 1,366,132 | 3.05B |
| 119 | KYMR | Kymera Therapeutics, Inc. | 9.19B | -1.33% | 448,205 | 105.00M |
| 120 | QGEN | Qiagen N.V. | 9.18B | -1.36% | 4,231,945 | 2.10B |
| 121 | OSCR | Oscar Health, Inc. | 9.18B | 0.40% | 3,796,367 | 15.32B |
| 122 | CYTK | Cytokinetics, Incorporated | 9.13B | -0.79% | 2,401,764 | 67.67M |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 9.12B | -1.03% | 507,933 | 281.99M |
| 124 | CAI | Caris Life Sciences, Inc. | 8.92B | -0.63% | 3,713,822 | 989.61M |
| 125 | PCVX | Vaxcyte, Inc. | 8.44B | -2.71% | 1,493,509 | - |
| 126 | ABVX | ABIVAX Société Anonyme | 8.28B | 1.70% | 1,628,204 | 5.33M |
| 127 | TGTX | TG Therapeutics, Inc. | 7.97B | - | 1,608,126 | 799.54M |
| 128 | PRAX | Praxis Precision Medicines, Inc. | 7.85B | -1.63% | 349,553 | 7.46M |
| 129 | ATR | AptarGroup, Inc. | 7.84B | -0.93% | 409,836 | 3.93B |
| 130 | HNGE | Hinge Health, Inc. | 7.68B | 2.99% | 1,724,709 | 720.06M |
| 131 | IONS | Ionis Pharmaceuticals, Inc. | 7.63B | 0.70% | 3,885,730 | 874.09M |
| 132 | SYRE | Spyre Therapeutics, Inc. | 7.47B | -1.25% | 1,053,246 | - |
| 133 | HQY | HealthEquity, Inc. | 7.22B | -1.35% | 1,021,808 | 1.36B |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 7.04B | -1.46% | 2,847,527 | 3.12B |
| 135 | IMVT | Immunovant, Inc. | 6.91B | -0.09% | 1,311,430 | - |
| 136 | ALKS | Alkermes plc | 6.84B | 1.62% | 2,686,816 | 1.67B |
| 137 | BLTE | Belite Bio, Inc | 6.71B | 0.44% | 186,874 | - |
| 138 | HIMS | Hims & Hers Health, Inc. | 6.70B | -0.28% | 6,581,540 | 2.58B |
| 139 | PACS | PACS Group, Inc. | 6.69B | -1.88% | 1,077,489 | 5.55B |
| 140 | CHE | Chemed Corporation | 6.66B | -0.44% | 118,307 | 2.60B |
| 141 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.59B | -2.89% | 810,796 | 239.92M |
| 142 | IOVA | Iovance Biotherapeutics, Inc. | 6.55B | 31.48% | 78,165,252 | 324.97M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.50B | -0.23% | 1,247,611 | 1.56B |
| 144 | GRFS | Grifols, S.A. | 6.44B | -1.55% | 485,001 | 8.48B |
| 145 | LQDA | Liquidia Corporation | 6.33B | -4.05% | 1,532,865 | 450.91M |
| 146 | CGON | CG Oncology, Inc. | 6.25B | 1.31% | 1,035,265 | 6.23M |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 6.19B | -1.19% | 430,955 | 290.54M |
| 148 | BLCO | Bausch + Lomb Corporation | 6.12B | 1.12% | 232,358 | 5.32B |
| 149 | GRAL | GRAIL, Inc. | 6.10B | 2.97% | 922,761 | 165.26M |
| 150 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.91B | -0.49% | 620,703 | 840.85M |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.82B | -2.81% | 1,066,721 | - |
| 152 | STVN | Stevanato Group S.p.A. | 5.79B | -0.98% | 205,904 | 1.40B |
| 153 | KOD | Kodiak Sciences Inc. | 5.72B | 1.33% | 6,047,113 | - |
| 154 | MIRM | Mirum Pharmaceuticals, Inc. | 5.68B | -0.48% | 666,806 | 618.07M |
| 155 | TVTX | Travere Therapeutics, Inc. | 5.65B | -2.57% | 1,546,670 | 591.33M |
| 156 | MMED | MiniMed Group, Inc. | 5.64B | -2.20% | 3,344,589 | 3.22B |
| 157 | BLLN | BillionToOne, Inc. | 5.58B | -2.91% | 440,261 | 397.41M |
| 158 | RDNT | RadNet, Inc. | 5.56B | -1.62% | 501,034 | 2.27B |
| 159 | COGT | Cogent Biosciences, Inc. | 5.50B | -0.63% | 1,704,644 | - |
| 160 | ORKA | Oruka Therapeutics, Inc. | 5.44B | -2.42% | 1,363,318 | - |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.42B | -1.50% | 900,435 | 1.01B |
| 162 | CRSP | CRISPR Therapeutics AG | 5.41B | 3.53% | 1,576,778 | 13.39M |
| 163 | TFX | Teleflex Incorporated | 5.35B | -0.83% | 982,574 | 2.25B |
| 164 | SHC | Sotera Health Company | 5.31B | 0.81% | 1,643,393 | 1.22B |
| 165 | MMSI | Merit Medical Systems, Inc. | 5.25B | 1.00% | 730,894 | 1.58B |
| 166 | DFTX | Definium Therapeutics, Inc. | 5.13B | -0.52% | 1,967,182 | - |
| 167 | ERAS | Erasca, Inc. | 4.97B | 0.57% | 3,203,318 | - |
| 168 | MANE | Veradermics, Incorporated | 4.92B | 2.45% | 481,702 | - |
| 169 | DNTH | Dianthus Therapeutics, Inc. | 4.88B | -0.76% | 1,033,852 | 1.90M |
| 170 | HAE | Haemonetics Corporation | 4.81B | 0.01% | 451,221 | 1.35B |
| 171 | WAY | Waystar Holding Corp. | 4.81B | -2.60% | 2,015,227 | 1.21B |
| 172 | ABCL | AbCellera Biologics Inc. | 4.80B | 6.47% | 9,110,372 | 66.17M |
| 173 | DOCS | Doximity, Inc. | 4.73B | 1.22% | 3,257,317 | 655.57M |
| 174 | ADPT | Adaptive Biotechnologies Corporation | 4.59B | 0.91% | 2,508,231 | 308.08M |
| 175 | LFST | LifeStance Health Group, Inc. | 4.54B | 0.42% | 3,451,815 | 1.58B |
| 176 | CON | Concentra Group Holdings Parent, Inc. | 4.51B | -0.06% | 587,399 | 2.29B |
| 177 | HTFL | HeartFlow, Inc. | 4.33B | -0.18% | 2,043,196 | 212.07M |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.32B | 1.89% | 2,005,495 | 1.33B |
| 179 | ITGR | Integer Holdings Corporation | 4.29B | -0.04% | 1,567,442 | 1.84B |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.26B | -1.51% | 1,920,009 | - |
| 181 | LIVN | LivaNova PLC | 4.24B | -0.28% | 567,968 | 1.47B |
| 182 | TNGX | Tango Therapeutics, Inc. | 4.12B | 0.49% | 2,992,154 | 53.81M |
| 183 | ICUI | ICU Medical, Inc. | 4.09B | -0.36% | 245,900 | 2.16B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.02B | 3.79% | 3,589,026 | 10.35M |
| 185 | PBLS | Parabilis Medicines, Inc. | 3.94B | -2.03% | 453,929 | 148.00K |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.83B | -2.41% | 428,307 | 890.79M |
| 187 | CELC | Celcuity Inc. | 3.79B | -2.84% | 1,221,680 | - |
| 188 | IRTC | iRhythm Holdings, Inc. | 3.77B | 1.44% | 443,174 | 825.34M |
| 189 | NVST | Envista Holdings Corporation | 3.75B | -1.69% | 2,989,845 | 2.86B |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.71B | -3.69% | 8,021,681 | - |
| 191 | VCYT | Veracyte, Inc. | 3.70B | 1.88% | 1,570,097 | 561.90M |
| 192 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.68B | -1.91% | 1,177,738 | -665.00K |
| 193 | IDYA | IDEAYA Biosciences, Inc. | 3.65B | -0.94% | 815,439 | 234.13M |
| 194 | LEGN | Legend Biotech Corporation | 3.65B | 1.07% | 1,974,366 | 1.27B |
| 195 | PLSE | Pulse Biosciences, Inc. | 3.63B | -2.73% | 516,936 | 1.19M |
| 196 | OGN | Organon & Co. | 3.61B | 0.07% | 1,628,743 | 6.13B |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.61B | 1.44% | 2,752,535 | 7.50M |
| 198 | NHC | National HealthCare Corporation | 3.51B | -0.80% | 105,144 | 1.56B |
| 199 | ACAD | Acadia Pharmaceuticals Inc. | 3.48B | -1.51% | 2,515,049 | 1.14B |
| 200 | OPCH | Option Care Health, Inc. | 3.42B | -0.39% | 1,757,954 | 5.69B |
| 201 | ELVN | Enliven Therapeutics, Inc. | 3.41B | 1.09% | 1,256,223 | - |
| 202 | WRBY | Warby Parker Inc. | 3.40B | 11.39% | 5,198,033 | 911.61M |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.37B | -0.16% | 417,966 | 606.33M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.36B | -2.12% | 2,936,918 | 463.98M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.33B | -0.81% | 1,390,299 | 3.60M |
| 206 | CDNA | CareDx, Inc. | 3.31B | -0.90% | 796,225 | 458.09M |
| 207 | RCUS | Arcus Biosciences, Inc. | 3.27B | 2.56% | 1,252,357 | 117.00M |
| 208 | RGC | Regencell Bioscience Holdings Limited | 3.07B | - | 54,521 | - |
| 209 | DYN | Dyne Therapeutics, Inc. | 3.03B | -0.80% | 2,289,351 | - |
| 210 | ATRC | AtriCure, Inc. | 2.95B | -0.62% | 876,274 | 569.62M |
| 211 | TMDX | TransMedics Group, Inc. | 2.92B | 1.62% | 440,127 | 668.47M |
| 212 | ZLAB | Zai Lab Limited | 2.91B | 0.93% | 549,095 | 449.61M |
| 213 | PGEN | Precigen, Inc. | 2.88B | 3.07% | 4,138,331 | 85.72M |
| 214 | NAMS | NewAmsterdam Pharma Company N.V. | 2.85B | 0.98% | 1,075,591 | 7.12M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.79B | 0.71% | 1,891,235 | 2.60B |
| 216 | MBX | MBX Biosciences, Inc. | 2.78B | 0.36% | 357,078 | - |
| 217 | NEOG | Neogen Corporation | 2.78B | -7.22% | 14,824,093 | 870.40M |
| 218 | BKD | Brookdale Senior Living Inc. | 2.62B | -0.54% | 4,475,923 | 2.93B |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.61B | 0.47% | 920,810 | 3.37B |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | -0.15% | 488,222 | 1.46B |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.56B | -1.41% | 551,584 | 830.44M |
| 222 | IRON | Disc Medicine, Inc. | 2.53B | 1.46% | 783,942 | - |
| 223 | PRVA | Privia Health Group, Inc. | 2.51B | -1.26% | 998,677 | 2.36B |
| 224 | AXGN | Axogen, Inc. | 2.49B | -2.12% | 1,407,685 | 251.17M |
| 225 | IMNM | Immunome, Inc. | 2.49B | 0.97% | 916,986 | 4.02M |
| 226 | CLDX | Celldex Therapeutics, Inc. | 2.48B | 0.48% | 2,029,408 | 158.00K |
| 227 | HCM | HUTCHMED (China) Limited | 2.47B | 0.14% | 46,202 | 549.12M |
| 228 | NRIX | Nurix Therapeutics, Inc. | 2.46B | 0.02% | 2,275,387 | 36.77M |
| 229 | BEAM | Beam Therapeutics Inc. | 2.45B | 1.20% | 1,637,448 | 156.04M |
| 230 | BFLY | Butterfly Network, Inc. | 2.42B | -0.55% | 6,699,873 | 112.14M |
| 231 | NEO | NeoGenomics, Inc. | 2.41B | -2.85% | 2,695,667 | 766.30M |
| 232 | TRLV | Trulieve Cannabis Corp. | 2.39B | 0.57% | 1,722,298 | 1.14B |
| 233 | VERA | Vera Therapeutics, Inc. | 2.33B | -0.38% | 1,457,448 | - |
| 234 | GPCR | Structure Therapeutics Inc. | 2.33B | -6.79% | 1,728,732 | - |
| 235 | SLS | SELLAS Life Sciences Group, Inc. | 2.32B | -0.69% | 3,267,199 | - |
| 236 | UFPT | UFP Technologies, Inc. | 2.30B | -0.77% | 88,319 | 631.64M |
| 237 | CLOV | Clover Health Investments, Corp. | 2.30B | -0.12% | 2,655,920 | 2.48B |
| 238 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | -1.80% | 786,675 | 959.90M |
| 239 | SDGR | Schrödinger, Inc. | 2.27B | 2.81% | 1,864,403 | 259.04M |
| 240 | ALMR | Alamar Biosciences, Inc. | 2.27B | 0.12% | 1,090,515 | 100.42M |
| 241 | VRDN | Viridian Therapeutics, Inc. | 2.27B | -2.80% | 1,233,587 | 71.13M |
| 242 | WGS | GeneDx Holdings Corp. | 2.26B | -11.80% | 1,334,392 | 454.43M |
| 243 | ADMA | ADMA Biologics, Inc. | 2.23B | -1.58% | 3,458,110 | 512.28M |
| 244 | PHVS | Pharvaris N.V. | 2.23B | -0.56% | 459,293 | - |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | -0.40% | 566,702 | 1.10B |
| 246 | ADRX | ADARx Pharmaceuticals, Inc. | 2.20B | 2.71% | 1,299,366 | 6.13M |
| 247 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -0.61% | 734,696 | 311.51M |
| 248 | BHC | Bausch Health Companies Inc. | 2.17B | 0.52% | 1,281,415 | 10.85B |
| 249 | MLYS | Mineralys Therapeutics, Inc. | 2.16B | -4.49% | 1,719,501 | - |
| 250 | RXRX | Recursion Pharmaceuticals, Inc. | 2.16B | 8.92% | 21,563,989 | 54.86M |
| 251 | INSP | Inspire Medical Systems, Inc. | 2.12B | 4.54% | 873,495 | 898.74M |
| 252 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.11B | -2.36% | 5,006,080 | 940.61M |
| 253 | ALVO | Alvotech | 2.11B | -3.74% | 1,169,798 | 494.61M |
| 254 | PRGO | Perrigo Company plc | 2.08B | -0.66% | 2,598,618 | 4.14B |
| 255 | VCEL | Vericel Corporation | 2.08B | 0.92% | 526,872 | 306.30M |
| 256 | MD | Pediatrix Medical Group, Inc. | 2.07B | 0.50% | 528,313 | 1.95B |
| 257 | ADUS | Addus HomeCare Corporation | 2.07B | 0.94% | 200,469 | 1.48B |
| 258 | TRVI | Trevi Therapeutics, Inc. | 2.05B | 0.14% | 2,045,164 | - |
| 259 | NKTR | Nektar Therapeutics | 2.02B | -1.92% | 1,816,393 | 54.59M |
| 260 | BHVN | Biohaven Ltd. | 2.01B | 0.15% | 1,533,992 | - |
| 261 | PVLA | Palvella Therapeutics, Inc. | 2.00B | -0.59% | 214,823 | - |
| 262 | AGIO | Agios Pharmaceuticals, Inc. | 1.99B | -0.36% | 416,406 | 98.34M |
| 263 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.99B | 0.26% | 1,755,082 | 208.78M |
| 264 | GENB | Generate Biomedicines, Inc. | 1.98B | 3.42% | 598,984 | 26.48M |
| 265 | URGN | UroGen Pharma Ltd. | 1.98B | -1.10% | 642,798 | 188.73M |
| 266 | NUVB | Nuvation Bio Inc. | 1.97B | 0.36% | 3,068,395 | 169.90M |
| 267 | SRPT | Sarepta Therapeutics, Inc. | 1.97B | -0.85% | 1,368,437 | 1.97B |
| 268 | ZYME | Zymeworks Inc. | 1.93B | 0.29% | 684,272 | 37.13M |
| 269 | BLFS | BioLife Solutions, Inc. | 1.92B | 0.18% | 573,538 | 106.69M |
| 270 | LKFT | Lakefront Biotherapeutics NV | 1.92B | -0.90% | 198,888 | 1.13B |
| 271 | MESO | Mesoblast Limited | 1.91B | 2.55% | 158,023 | 120.25M |
| 272 | PGNY | Progyny, Inc. | 1.90B | -2.86% | 1,551,984 | 1.31B |
| 273 | ESTA | Establishment Labs Holdings Inc. | 1.90B | -2.51% | 516,870 | 245.82M |
| 274 | LMAT | LeMaitre Vascular, Inc. | 1.90B | 0.67% | 227,143 | 262.43M |
| 275 | FTRE | Fortrea Holdings Inc. | 1.88B | -1.60% | 1,170,629 | 2.68B |
| 276 | SGRY | Surgery Partners, Inc. | 1.87B | -1.91% | 1,421,019 | 3.37B |
| 277 | NVCR | NovoCure Limited | 1.86B | 1.01% | 728,540 | 699.19M |
| 278 | XNCR | Xencor, Inc. | 1.86B | -2.34% | 1,620,956 | 104.97M |
| 279 | SEPN | Septerna, Inc. | 1.83B | -1.53% | 564,501 | 98.88M |
| 280 | XERS | Xeris Biopharma Holdings, Inc. | 1.82B | 1.53% | 19,314,578 | 335.41M |
| 281 | ASTH | Astrana Health, Inc. | 1.81B | 0.91% | 264,254 | 3.84B |
| 282 | VIR | Vir Biotechnology, Inc. | 1.80B | 1.33% | 1,573,680 | 303.23M |
| 283 | CMPS | COMPASS Pathways plc | 1.79B | -2.04% | 2,499,909 | - |
| 284 | XRAY | DENTSPLY SIRONA Inc. | 1.79B | -3.23% | 4,599,171 | 3.64B |
| 285 | NVAX | Novavax, Inc. | 1.78B | 0.19% | 4,071,341 | 413.80M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.78B | - | 328,481 | 481.07M |
| 287 | PSNL | Personalis, Inc. | 1.75B | 0.18% | 1,037,827 | 69.67M |
| 288 | ZBIO | Zenas BioPharma, Inc. | 1.74B | -2.87% | 440,627 | 1.00M |
| 289 | ABSI | Absci Corporation | 1.74B | 6.85% | 3,423,505 | 1.56M |
| 290 | OCUL | Ocular Therapeutix, Inc. | 1.73B | 2.81% | 5,286,682 | 52.06M |
| 291 | FRNM | Freenome, Inc. | 1.71B | -1.67% | 508,215 | 35.41M |
| 292 | QURE | uniQure N.V. | 1.70B | -37.33% | 29,813,991 | 18.67M |
| 293 | KMTS | Kestra Medical Technologies, Ltd. | 1.70B | 1.17% | 454,866 | 106.73M |
| 294 | GHRS | GH Research PLC | 1.69B | 5.34% | 1,131,961 | - |
| 295 | ETON | Eton Pharmaceuticals, Inc. | 1.69B | 0.02% | 710,603 | 105.60M |
| 296 | NTLA | Intellia Therapeutics, Inc. | 1.69B | 5.34% | 5,017,506 | 59.51M |
| 297 | STOK | Stoke Therapeutics, Inc. | 1.67B | 1.49% | 1,076,502 | 27.59M |
| 298 | ALHC | Alignment Healthcare, Inc. | 1.64B | -0.25% | 7,075,672 | 4.58B |
| 299 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | 2.10% | 1,499,417 | 252.25M |
| 300 | TSHA | Taysha Gene Therapies, Inc. | 1.63B | - | 6,570,231 | 5.49M |
| 301 | ATEC | Alphatec Holdings, Inc. | 1.60B | 3.18% | 1,725,684 | 815.05M |
| 302 | NBTX | Nanobiotix S.A. | 1.59B | -3.37% | 163,482 | 13.15M |
| 303 | IMCR | Immunocore Holdings plc | 1.59B | 0.69% | 344,214 | 430.78M |
| 304 | RAPP | Rapport Therapeutics, Inc. | 1.58B | -1.26% | 626,149 | 20.00M |
| 305 | OMCL | Omnicell, Inc. | 1.57B | 1.30% | 573,463 | 1.25B |
| 306 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | -2.95% | 328,739 | 978.38M |
| 307 | KRSA | Korsana Biosciences, Inc. | 1.55B | 10.28% | 96,837 | - |
| 308 | INBX | Inhibrx Biosciences, Inc. | 1.54B | 3.07% | 240,921 | 1.30M |
| 309 | INVA | Innoviva, Inc. | 1.53B | -0.57% | 555,805 | 440.00M |
| 310 | COAG | Hemab Therapeutics Holdings, Inc. | 1.52B | -1.57% | 452,038 | - |
| 311 | TYRA | Tyra Biosciences, Inc. | 1.51B | 2.47% | 501,793 | - |
| 312 | ANAB | AnaptysBio, Inc. | 1.51B | -0.85% | 677,564 | 106.09M |
| 313 | RARE | Ultragenyx Pharmaceutical Inc. | 1.51B | 6.32% | 5,884,651 | 717.00M |
| 314 | AZTA | Azenta, Inc. | 1.50B | 0.09% | 813,906 | 613.81M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.50B | 0.63% | 709,487 | 20.00M |
| 316 | ARDT | Ardent Health, Inc. | 1.49B | 1.05% | 396,293 | 6.41B |
| 317 | BRVE | Braveheart Bio, Inc. | 1.46B | 6.03% | 717,776 | - |
| 318 | AVBP | ArriVent BioPharma, Inc. | 1.46B | 0.82% | 780,003 | - |
| 319 | PAHC | Phibro Animal Health Corporation | 1.44B | -0.70% | 170,538 | 1.52B |
| 320 | NUTX | Nutex Health Inc. | 1.44B | -1.24% | 147,654 | 846.72M |
| 321 | HCSG | Healthcare Services Group, Inc. | 1.43B | 0.58% | 513,001 | 1.86B |
| 322 | KLRA | Kailera Therapeutics, Inc. | 1.42B | -1.17% | 694,822 | - |
| 323 | AAPG | Ascentage Pharma Group International | 1.42B | 3.09% | 3,387 | 94.61M |
| 324 | PNTG | The Pennant Group, Inc. | 1.41B | -0.98% | 311,262 | 1.10B |
| 325 | CERT | Certara, Inc. | 1.41B | 1.42% | 2,936,290 | 421.75M |
| 326 | DRTS | Alpha Tau Medical Ltd. | 1.40B | 1.00% | 513,857 | - |
| 327 | CNMD | CONMED Corporation | 1.40B | 0.45% | 228,993 | 1.37B |
| 328 | OMER | Omeros Corporation | 1.39B | -0.93% | 841,695 | 38.42M |
| 329 | ORIC | ORIC Pharmaceuticals, Inc. | 1.39B | 0.75% | 977,252 | - |
| 330 | KARD | Kardigan, Inc. | 1.37B | -0.81% | 493,600 | - |
| 331 | AMN | AMN Healthcare Services, Inc. | 1.35B | 2.01% | 660,061 | 3.43B |
| 332 | AGL | agilon health, inc. | 1.31B | -1.74% | 181,097 | 5.92B |
| 333 | IART | Integra LifeSciences Holdings Corporation | 1.29B | 2.27% | 1,005,196 | 1.65B |
| 334 | SVRA | Savara Inc. | 1.29B | 0.20% | 2,034,626 | - |
| 335 | TRAX | First Tracks Biotherapeutics, Inc. | 1.29B | -1.83% | 645,545 | - |
| 336 | USPH | U.S. Physical Therapy, Inc. | 1.29B | 0.07% | 208,096 | 804.27M |
| 337 | DMRA | Damora Therapeutics, Inc. | 1.28B | -0.43% | 376,391 | - |
| 338 | CRON | Cronos Group Inc. | 1.26B | -0.88% | 761,987 | 179.09M |
| 339 | BCAX | Bicara Therapeutics Inc. | 1.23B | -1.28% | 599,779 | - |
| 340 | INNV | InnovAge Holding Corp. | 1.23B | 1.01% | 729,129 | 989.71M |
| 341 | REPL | Replimune Group, Inc. | 1.22B | 3.50% | 4,365,272 | - |
| 342 | OPK | OPKO Health, Inc. | 1.21B | -0.61% | 1,727,841 | 587.90M |
| 343 | LBRX | LB Pharmaceuticals Inc | 1.20B | -1.61% | 713,377 | - |
| 344 | AVLN | Avalyn Pharma Inc. | 1.20B | -4.31% | 421,890 | - |
| 345 | LTGO | Latigo Biotherapeutics, Inc. | 1.20B | 3.55% | 955,172 | - |
| 346 | OMDA | Omada Health, Inc. | 1.19B | -0.10% | 1,180,064 | 309.76M |
| 347 | BVS | Bioventus Inc. | 1.18B | - | 449,071 | 581.85M |
| 348 | HROW | Harrow, Inc. | 1.18B | -0.63% | 396,804 | 275.59M |
| 349 | IMTX | Immatics N.V. | 1.17B | 0.71% | 644,299 | 47.65M |
| 350 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 0.91% | 1,892,483 | 1.04B |
| 351 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.13B | -2.59% | 631,995 | 730.02M |
| 352 | STAA | STAAR Surgical Company | 1.12B | 7.47% | 1,656,660 | 339.59M |
| 353 | AORT | Artivion, Inc. | 1.11B | -0.39% | 336,580 | 471.47M |
| 354 | IRMD | IRADIMED CORPORATION | 1.11B | -0.23% | 204,793 | 86.34M |
| 355 | GDRX | GoodRx Holdings, Inc. | 1.10B | -2.42% | 587,956 | 785.23M |
| 356 | AKTS | Aktis Oncology, Inc. | 1.10B | 1.76% | 194,637 | 10.06M |
| 357 | VOR | Vor Biopharma Inc. | 1.08B | 0.11% | 1,383,942 | - |
| 358 | ODTX | Odyssey Therapeutics, Inc. | 1.08B | 4.52% | 201,689 | 99.00K |
| 359 | MNKD | MannKind Corporation | 1.07B | -0.30% | 2,381,153 | 393.63M |
| 360 | MGTX | MeiraGTx Holdings plc | 1.07B | 0.18% | 875,926 | 397.50M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.07B | -2.92% | 318,529 | 357.28M |
| 362 | ENOV | Enovis Corporation | 1.06B | 1.65% | 1,531,517 | 2.30B |
| 363 | TDOC | Teladoc Health, Inc. | 1.04B | -2.38% | 3,749,883 | 2.49B |
| 364 | SLBT | SL Science Holding Limited | 1.04B | -5.18% | 29,649 | 3.27M |
| 365 | PRCT | PROCEPT BioRobotics Corporation | 1.04B | 5.62% | 2,186,319 | 337.34M |
| 366 | ANRO | Alto Neuroscience, Inc. | 1.04B | -0.30% | 763,380 | - |
| 367 | JANX | Janux Therapeutics, Inc. | 1.04B | 2.23% | 511,702 | 24.00M |
| 368 | PCRX | Pacira BioSciences, Inc. | 1.02B | 1.02% | 643,596 | 746.16M |
| 369 | BBNX | Beta Bionics, Inc. | 1.02B | -5.41% | 842,604 | 119.01M |
| 370 | ANL | Adlai Nortye Group Ltd. | 1.01B | 2.14% | 63,027 | 18.06M |
| 371 | GLUE | Monte Rosa Therapeutics, Inc. | 1.00B | 0.26% | 545,064 | 28.73M |
| 372 | SPTX | Seaport Therapeutics, Inc. | 1.00B | -4.84% | 288,867 | - |
| 373 | APMD | Apnimed, Inc. | 994.98M | 10.29% | 670,210 | 115.12M |
| 374 | CRVS | Corvus Pharmaceuticals, Inc. | 989.26M | -0.93% | 881,944 | - |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 985.73M | 1.08% | 379,572 | 1.04B |
| 376 | CGEM | Cullinan Therapeutics, Inc. | 980.12M | 1.87% | 1,244,361 | - |
| 377 | MLTX | MoonLake Immunotherapeutics | 974.47M | -0.95% | 1,506,991 | - |
| 378 | KURA | Kura Oncology, Inc. | 961.22M | 1.84% | 1,890,157 | 77.23M |
| 379 | CBLL | CeriBell, Inc. | 954.08M | 1.43% | 300,860 | 101.96M |
| 380 | ALMS | Alumis Inc. | 943.58M | 1.82% | 1,668,138 | 7.40M |
| 381 | ABUS | Arbutus Biopharma Corporation | 927.91M | -3.50% | 17,557,048 | 181.72M |
| 382 | HELP | Cybin Inc. | 927.86M | 0.87% | 972,391 | - |
| 383 | RIGL | Rigel Pharmaceuticals, Inc. | 913.26M | -0.95% | 182,182 | 276.79M |
| 384 | HSTM | HealthStream, Inc. | 909.92M | 2.06% | 153,586 | 321.12M |
| 385 | JBIO | Jade Biosciences, Inc. | 901.81M | -1.18% | 629,533 | - |
| 386 | OBX | Obsidian Therapeutics, Inc. | 900.65M | 9.05% | 378,583 | - |
| 387 | SANA | Sana Biotechnology, Inc. | 871.14M | -0.68% | 3,047,655 | - |
| 388 | SIBN | SI-BONE, Inc. | 858.28M | 2.08% | 624,129 | 213.60M |
| 389 | SGP | SpyGlass Pharma, Inc. | 851.92M | -1.96% | 67,864 | - |
| 390 | ARDX | Ardelyx, Inc. | 844.75M | -0.59% | 4,434,043 | 450.89M |
| 391 | LXRX | Lexicon Pharmaceuticals, Inc. | 836.52M | -1.05% | 3,946,247 | 41.47M |
| 392 | AVTX | Avalo Therapeutics, Inc. | 835.56M | 3.32% | 1,331,567 | 59.00K |
| 393 | CADL | Candel Therapeutics, Inc. | 832.52M | -2.77% | 963,288 | - |
| 394 | ATTO | Attovia Therapeutics, Inc. | 829.03M | 2.89% | 887,157 | 1.80M |
| 395 | INMD | InMode Ltd. | 817.38M | 0.07% | 362,732 | 374.63M |
| 396 | DNA | Ginkgo Bioworks Holdings, Inc. | 805.39M | 14.34% | 4,722,175 | 132.42M |
| 397 | FDMT | 4D Molecular Therapeutics, Inc. | 800.49M | -0.48% | 1,376,232 | 92.01M |
| 398 | GERN | Geron Corporation | 796.67M | -0.80% | 12,498,949 | 204.56M |
| 399 | ACHV | Achieve Life Sciences, Inc. | 791.32M | -0.77% | 1,029,828 | - |
| 400 | DSGN | Design Therapeutics, Inc. | 789.78M | 2.10% | 655,797 | - |
| 401 | ANNX | Annexon, Inc. | 782.96M | 2.99% | 3,706,508 | - |
| 402 | VREX | Varex Imaging Corporation | 778.47M | 0.05% | 206,060 | 865.00M |
| 403 | ACRS | Aclaris Therapeutics, Inc. | 777.21M | -2.76% | 2,051,626 | 8.22M |
| 404 | GYRE | Gyre Therapeutics, Inc. | 776.17M | -2.27% | 115,115 | 109.82M |
| 405 | IVA | Inventiva S.A. | 768.41M | -6.80% | 3,832,494 | 2.81M |
| 406 | SLDB | Solid Biosciences Inc. | 767.73M | -1.65% | 1,392,240 | - |
| 407 | GMRS | GMR Solutions Inc. | 764.78M | -1.80% | 598,119 | 5.88B |
| 408 | AHCO | AdaptHealth Corp. | 756.43M | 0.35% | 2,453,989 | 3.36B |
| 409 | IMMX | Immix Biopharma, Inc. | 754.02M | -8.11% | 5,760,424 | - |
| 410 | CTKB | Cytek Biosciences, Inc. | 748.70M | 0.35% | 869,864 | 206.71M |
| 411 | OLMA | Olema Pharmaceuticals, Inc. | 747.23M | -0.81% | 1,081,253 | - |
| 412 | AVR | Anteris Technologies Global Corp. | 739.71M | -1.94% | 782,364 | 2.24M |
| 413 | QDEL | QuidelOrtho Corporation | 726.56M | -2.17% | 895,464 | 2.67B |
| 414 | FTH | Faeth Therapeutics, Inc. | 725.34M | 1.08% | 250,786 | - |
| 415 | COLL | Collegium Pharmaceutical, Inc. | 723.71M | -1.77% | 1,022,584 | 808.21M |
| 416 | VSTM | Verastem, Inc. | 717.26M | 1.93% | 2,677,145 | 87.53M |
| 417 | WVE | Wave Life Sciences, Inc. | 717.26M | -0.82% | 2,765,536 | 65.37M |
| 418 | ETRA | Electra Therapeutics, Inc. | 712.40M | 0.27% | 715,622 | - |
| 419 | PHAR | Pharming Group N.V. | 710.75M | -4.85% | 26,266 | 366.48M |
| 420 | SOPH | SOPHiA GENETICS SA | 706.56M | -2.24% | 301,555 | 86.17M |
| 421 | OABI | OmniAb, Inc. | 689.15M | - | 1,391,878 | 38.46M |
| 422 | IRWD | Ironwood Pharmaceuticals, Inc. | 687.40M | 0.97% | 1,233,147 | 389.32M |
| 423 | MDXG | MiMedx Group, Inc. | 680.70M | -0.21% | 901,197 | 355.17M |
| 424 | BLSM | BlossomHill Therapeutics, Inc. | 679.24M | 0.14% | 228,480 | - |
| 425 | DBVT | DBV Technologies S.A. | 676.66M | -0.77% | 199,499 | 5.04M |
| 426 | ZVRA | Zevra Therapeutics, Inc. | 673.41M | 0.35% | 1,340,498 | 136.07M |
| 427 | NVCT | Nuvectis Pharma, Inc. | 669.22M | -1.30% | 160,030 | - |
| 428 | STLN | Starling Oncology, Inc. | 663.47M | -1.96% | 972,863 | 587.24M |
| 429 | CLYM | Climb Bio, Inc. | 660.52M | -2.04% | 1,140,421 | - |
| 430 | STTK | Shattuck Labs, Inc. | 656.38M | 1.71% | 956,827 | 1.00M |
| 431 | SLN | Silence Therapeutics plc | 650.26M | -3.57% | 884,614 | 615.00K |
| 432 | ANGO | AngioDynamics, Inc. | 644.79M | 0.39% | 862,092 | 320.17M |
| 433 | GLAS | Glass House Brands Inc. | 639.91M | -0.88% | 1,326,303 | 176.98M |
| 434 | AURA | Aura Biosciences, Inc. | 637.78M | - | 795,445 | - |
| 435 | CBIO | Crescent Biopharma, Inc. | 631.74M | 1.58% | 684,623 | 11.88M |
| 436 | PHR | Phreesia, Inc. | 621.33M | -0.89% | 570,693 | 507.79M |
| 437 | CRMD | CorMedix Inc. | 618.10M | 0.51% | 817,285 | 462.25M |
| 438 | FLGT | Fulgent Genetics, Inc. | 607.54M | -1.25% | 234,844 | 323.93M |
| 439 | CTMX | CytomX Therapeutics, Inc. | 599.22M | 2.23% | 4,457,000 | 18.30M |
| 440 | KIDS | OrthoPediatrics Corp. | 594.26M | 0.80% | 99,731 | 252.72M |
| 441 | EVO | Evotec SE | 594.18M | 3.14% | 94,929 | 819.47M |
| 442 | AHG | Akso Health Group | 591.98M | -5.47% | 32,869 | 13.83M |
| 443 | WEAV | Weave Communications, Inc. | 588.79M | -0.14% | 1,254,493 | 257.79M |
| 444 | AQST | Aquestive Therapeutics, Inc. | 586.14M | -1.68% | 1,708,397 | 54.09M |
| 445 | PHAT | Phathom Pharmaceuticals, Inc. | 584.61M | 0.14% | 657,239 | 239.66M |
| 446 | SGMT | Sagimet Biosciences Inc. | 579.94M | -6.14% | 860,048 | - |
| 447 | SSII | SS Innovations International, Inc. | 579.11M | - | 54,564 | 52.40M |
| 448 | ALT | Altimmune, Inc. | 577.72M | 0.34% | 2,563,649 | 31.00K |
| 449 | VALN | Valneva SE | 577.43M | -5.10% | 9,535 | 163.30M |
| 450 | PACB | Pacific Biosciences of California, Inc. | 568.82M | 7.02% | 17,423,808 | 159.27M |
| 451 | NGNE | Neurogene Inc. | 568.12M | -0.32% | 176,722 | 925.00K |
| 452 | MPLT | MapLight Therapeutics, Inc. | 564.09M | -2.87% | 408,312 | - |
| 453 | OCS | Oculis Holding AG | 563.61M | 0.77% | 373,456 | 1.45M |
| 454 | ALLO | Allogene Therapeutics, Inc. | 559.70M | -0.61% | 4,318,917 | 4.64M |
| 455 | EPRX | Eupraxia Pharmaceuticals Inc. | 550.58M | 1.16% | 645,107 | - |
| 456 | DCTH | Delcath Systems, Inc. | 549.98M | 0.25% | 263,696 | 95.42M |
| 457 | PRME | Prime Medicine, Inc. | 549.72M | 7.48% | 3,605,632 | 4.07M |
| 458 | TLRY | Tilray Brands, Inc. | 541.12M | -1.74% | 3,500,842 | 915.45M |
| 459 | YDES | YD Bio Limited | 539.03M | 7.03% | 349,714 | 1.24M |
| 460 | MNPR | Monopar Therapeutics Inc. | 536.97M | -4.44% | 162,395 | - |
| 461 | SENS | Senseonics Holdings, Inc. | 531.38M | 2.13% | 606,989 | 48.55M |
| 462 | EOLS | Evolus, Inc. | 527.74M | 0.38% | 414,953 | 316.49M |
| 463 | BWAY | BrainsWay Ltd. | 525.57M | 1.74% | 113,402 | 60.70M |
| 464 | AGMB | AgomAb Therapeutics NV | 518.58M | 3.13% | 113,491 | - |
| 465 | SGHT | Sight Sciences, Inc. | 515.07M | 0.86% | 495,495 | 83.38M |
| 466 | TCMD | Tactile Systems Technology, Inc. | 511.04M | -1.14% | 220,937 | 350.31M |
| 467 | DRUG | Bright Minds Biosciences Inc. | 511.00M | -3.72% | 96,741 | - |
| 468 | PBYI | Puma Biotechnology, Inc. | 504.84M | -0.41% | 220,539 | 231.24M |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 470 | KMDA | Kamada Ltd. | 498.65M | 0.87% | 48,341 | 191.85M |
| 471 | CAPR | Capricor Therapeutics, Inc. | 498.25M | -1.61% | 2,674,690 | 11.13M |
| 472 | CERS | Cerus Corporation | 497.77M | 0.82% | 1,621,335 | 221.55M |
| 473 | OVID | Ovid Therapeutics Inc. | 496.06M | 3.25% | 1,163,592 | 1.58M |
| 474 | AUTL | Autolus Therapeutics plc | 495.06M | - | 1,770,892 | 117.39M |
| 475 | PROK | ProKidney Corp. | 492.79M | 1.24% | 1,003,272 | 818.00K |
| 476 | RGNX | REGENXBIO Inc. | 491.80M | -0.27% | 2,096,029 | 174.48M |
| 477 | ARVN | Arvinas, Inc. | 490.40M | -0.13% | 496,011 | 316.70M |
| 478 | MASS | 908 Devices Inc. | 489.80M | 1.63% | 453,454 | 60.84M |
| 479 | TKNO | Alpha Teknova, Inc. | 487.49M | -1.30% | 349,662 | 43.70M |
| 480 | NPCE | NeuroPace, Inc. | 478.48M | -1.48% | 100,580 | 106.99M |
| 481 | ASMB | Assembly Biosciences, Inc. | 478.07M | -0.55% | 229,736 | 74.85M |
| 482 | ENTX | Entera Bio Ltd. | 465.75M | - | 160,824 | 42.00K |
| 483 | NRC | NRC Health | 465.62M | 4.94% | 135,901 | 140.00M |
| 484 | TECX | Tectonic Therapeutic, Inc. | 456.28M | -0.72% | 1,050,103 | - |
| 485 | SRTA | Strata Critical Medical, Inc. | 451.18M | -2.49% | 1,216,151 | 255.98M |
| 486 | PRTA | Prothena Corporation plc | 450.74M | 0.69% | 602,274 | 54.53M |
| 487 | AGEN | Agenus Inc. | 445.25M | 4.88% | 1,501,456 | 132.69M |
| 488 | DMAC | DiaMedica Therapeutics Inc. | 442.19M | -1.44% | 231,059 | - |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 437.57M | 6.54% | 1,274,703 | 116.93M |
| 490 | SCTX | Scribe Therapeutics Inc. | 436.00M | 5.79% | 671,395 | 33.30M |
| 491 | CTNM | Contineum Therapeutics, Inc. | 432.64M | -9.66% | 856,143 | - |
| 492 | RZLT | Rezolute, Inc. | 429.03M | -2.15% | 1,518,965 | - |
| 493 | EIKN | Eikon Therapeutics, Inc. | 428.45M | - | 334,819 | - |
| 494 | KYTX | Kyverna Therapeutics, Inc. | 423.01M | 0.29% | 827,665 | - |
| 495 | AVIR | Atea Pharmaceuticals, Inc. | 415.46M | -0.38% | 298,326 | - |
| 496 | IRD | Opus Genetics, Inc. | 412.24M | -1.88% | 1,525,569 | 9.86M |
| 497 | PRLD | Prelude Therapeutics Incorporated | 407.86M | 1.28% | 457,879 | 22.42M |
| 498 | MYGN | Myriad Genetics, Inc. | 404.60M | -0.24% | 1,599,234 | 806.60M |
| 499 | TTRX | Turn Therapeutics Inc. | 399.46M | 2.84% | 79,533 | - |
| 500 | EVH | Evolent Health, Inc. | 397.97M | -3.56% | 3,261,505 | 2.10B |